This course covers; cardiovascular statistics and risk factors, the recommendations in NICE Guideline 238, the drugs used to treat hypercholesterolaemia; statins, ezetimibe, PCSK9 inhibitors, bempedoic acid, inclisiran and icosapent ethyl. It considers the national lipid management pathway and how the drugs fit into the treatment pathway.
Three case studies consider statins for primary prevention, secondary prevention and statin intolerance.
Approx time to complete: 3 hours over several sittings